JR11 - Oral communication - Claire GUISSART

JR11 - Oral communication - Claire GUISSART

🎙 Claire GUISSART 👥 1K 📅 January 28, 2026 ⏱ 13 min 👁 12 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

ALSRNA-Seqsplicingmolecular diagnosisvariant classification

Summary

Claire Guissart presents a targeted RNA-Seq approach to improve molecular diagnosis of ALS, focusing on intronic splicing variants that are often classified as variants of uncertain significance. The project aims to develop bioinformatic pipelines, improve splicing variant classification, and identify new mutations. Over 400 patients were included, with 80 RNA analyses performed. Among 37 patients with splicing variants, 11 were confirmed deleterious. The pipeline, developed with collaborators, combines statistical and non-statistical splice junctions and generates reports with sashimi plots. Case studies illustrate the impact of variants on splicing, including exon skipping, cryptic splice site usage, and intron retention, leading to frameshifts and premature termination codons. Future developments include improving detection of intron retention and quantitative defects, and blind detection of splicing anomalies. The presentation emphasizes the importance of testing sporadic ALS cases and integrating RNA preservation into routine diagnostics.

139 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable data on the utility of targeted RNA-Seq in resolving uncertain splicing variants in ALS. The argumentation is solid, supported by concrete case studies and quantitative results (11 out of 37 variants reclassified). The methodology is clearly explained, and limitations are acknowledged, such as the pipeline not detecting intron retention. The speaker effectively demonstrates the clinical impact of the approach.

72 words

Title / Content Match

Title accurately reflects the content: an oral communication on targeted RNA-Seq for ALS molecular diagnosis.

Quality & Reliability

8/10

Presentation of original research with clear methodology, data from 400 patients, and functional validation of splicing variants. Limitations acknowledged (pipeline not detecting all events).

Key Moments

Contribution & Novelties

The presentation introduces a targeted RNA-Seq approach specifically for ALS molecular diagnosis, addressing the challenge of classifying intronic splicing variants. The novelty lies in the systematic integration of RNA analysis into routine diagnostics and the development of a bioinformatic pipeline with feedback optimization. The approach has led to reclassification of variants and resolution of cases, demonstrating its clinical utility.

Pour aller plus loin :

111 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and reliability, with a slightly lower technical level, indicating a well-balanced presentation accessible to a specialized audience.

Reliability 8/10